{"title":"Mechanisms of inhibin signal transduction.","authors":"D. Bernard, S. Chapman, T. Woodruff","doi":"10.1210/RP.56.1.417","DOIUrl":null,"url":null,"abstract":"Inhibin was first identified as a gonadal hormone that potently inhibits pituitary follicle-stimulating hormone (FSH) synthesis and secretion. Although the notion of a nonsteroidal, gonadally derived inhibitory substance was realized in the early 1930s (McCullagh, 1932), identification of the hormone was not accomplished until more than 50 years later. At that time, inhibin was purified from bovine and porcine follicular fluid and was shown to be produced in two forms through dimeric assembly of an alpha subunit (18 kDa) and one of two closely related beta subunits (betaA and betaB, approximately 14 kDa) (Ling et al., 1985; Miyamoto et al., 1985; Rivier et al., 1985; Robertson et al., 1985). Dimers of alpha and betaA and alpha and betaB subunits form inhibin A and inhibin B, respectively. In the process of purifying inhibin, two groups also identified homo- and heterodimers of the inhibin beta subunits (Ling et al., 1986; Vale et al., 1986). These hormones, the activins, were shown to potently stimulate FSH secretion from primary pituitary cultures and are now known to play important roles in growth and development (Woodruff, 1998; Pangas and Woodruff, 2000). Inhibins and activins are considered members of the transforming growth factor-beta (TGF-beta) superfamily of growth and differentiation factors, based on a pattern of conserved cysteine residues in the alpha and beta subunits, similar to other ligands in the family. Identification of the subunit proteins led to the cloning of their cDNAs and subsequently to their chromosomal mapping in several species (Mason et al, 1985,1986; Forage et al., 1986; Mayo et al., 1986; Esch et al., 1987; Woodruff et al., 1987; Barton et al., 1989; Hiendleder et al., 2000). Three additional activin-related beta subunits (betaC and betaE in mammals and betaD in Xenopus laevis) also have been identified but do not appear to play a role in FSH regulation (Hotten et al., 1995; Oda et al., 1995; Fang et al., 1996, 1997; Loveland et al., 1996; Schmitt el al., 1996; O'Bryan et al., 2000; Lau et al., 2000). To date, only one alpha subunit has been reported. The inhibin subunits are expressed in various tissues (Meunier et al., 1988a, 1988b) but the gonads are clearly the primary source of circulating inhibins (Woodruff et al., 1996). While inhibins act in a paracrine role in some tissues (Hsueh et al., 1987), their best-understood roles are as endocrine regulators of pituitary FSH. Activins also were purified from follicular fluid but because circulating activin levels generally are low, most actions of the hormones are likely to be paracrine in nature (Woodruff, 1998). Several reviews in the past decade have clearly and thoroughly addressed the characterization and regulation of the inhibins and activins and their roles in reproductive function (Vale et al., 1988; Ying, 1988; Woodruff and Mayo, 1990; Mayo, 1994; Woodruff and Mather, 1995). In this chapter, we focus our attention on more-recent developments in inhibin research. First, we discuss differential regulation of inhibin isoforms. Specifically, we describe patterns of inhibin A and B secretion in the context of the female reproductive cycle. Second, we review molecular mechanisms of inhibin subunit regulation. Third, while inhibins are best known for their role in pituitary FSH regulation, other functions of the ligands are becoming better understood. We review the animal and human literature addressing the possible role of inhibins in gonadal cancers. While we know \"what\" inhibins do in various contexts, we have a very limited understanding of \"how\" the ligands have their effects on target cells. Recently, candidate inhibin receptor molecules have been identified (Draper et al., 1998; Hertan et al., 1999; Lewis et al., 2000; Chung et al., 2000). Next, we detail our current understanding of inhibin signal transduction. Finally, in light of the data reviewed here, we pose questions and outline future directions for inhibin research. While this review is concerned primarily with expression and function of inhibin, activin function and mechanisms of action are described where necessary to shed light on inhibin function. Several reviews of activin's role in reproductive and other processes can be found elsewhere (Woodruff, 1998; Pangas and Woodruff, 2000).","PeriodicalId":21099,"journal":{"name":"Recent progress in hormone research","volume":"1150 1","pages":"417-50"},"PeriodicalIF":0.0000,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"91","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent progress in hormone research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/RP.56.1.417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 91
Abstract
Inhibin was first identified as a gonadal hormone that potently inhibits pituitary follicle-stimulating hormone (FSH) synthesis and secretion. Although the notion of a nonsteroidal, gonadally derived inhibitory substance was realized in the early 1930s (McCullagh, 1932), identification of the hormone was not accomplished until more than 50 years later. At that time, inhibin was purified from bovine and porcine follicular fluid and was shown to be produced in two forms through dimeric assembly of an alpha subunit (18 kDa) and one of two closely related beta subunits (betaA and betaB, approximately 14 kDa) (Ling et al., 1985; Miyamoto et al., 1985; Rivier et al., 1985; Robertson et al., 1985). Dimers of alpha and betaA and alpha and betaB subunits form inhibin A and inhibin B, respectively. In the process of purifying inhibin, two groups also identified homo- and heterodimers of the inhibin beta subunits (Ling et al., 1986; Vale et al., 1986). These hormones, the activins, were shown to potently stimulate FSH secretion from primary pituitary cultures and are now known to play important roles in growth and development (Woodruff, 1998; Pangas and Woodruff, 2000). Inhibins and activins are considered members of the transforming growth factor-beta (TGF-beta) superfamily of growth and differentiation factors, based on a pattern of conserved cysteine residues in the alpha and beta subunits, similar to other ligands in the family. Identification of the subunit proteins led to the cloning of their cDNAs and subsequently to their chromosomal mapping in several species (Mason et al, 1985,1986; Forage et al., 1986; Mayo et al., 1986; Esch et al., 1987; Woodruff et al., 1987; Barton et al., 1989; Hiendleder et al., 2000). Three additional activin-related beta subunits (betaC and betaE in mammals and betaD in Xenopus laevis) also have been identified but do not appear to play a role in FSH regulation (Hotten et al., 1995; Oda et al., 1995; Fang et al., 1996, 1997; Loveland et al., 1996; Schmitt el al., 1996; O'Bryan et al., 2000; Lau et al., 2000). To date, only one alpha subunit has been reported. The inhibin subunits are expressed in various tissues (Meunier et al., 1988a, 1988b) but the gonads are clearly the primary source of circulating inhibins (Woodruff et al., 1996). While inhibins act in a paracrine role in some tissues (Hsueh et al., 1987), their best-understood roles are as endocrine regulators of pituitary FSH. Activins also were purified from follicular fluid but because circulating activin levels generally are low, most actions of the hormones are likely to be paracrine in nature (Woodruff, 1998). Several reviews in the past decade have clearly and thoroughly addressed the characterization and regulation of the inhibins and activins and their roles in reproductive function (Vale et al., 1988; Ying, 1988; Woodruff and Mayo, 1990; Mayo, 1994; Woodruff and Mather, 1995). In this chapter, we focus our attention on more-recent developments in inhibin research. First, we discuss differential regulation of inhibin isoforms. Specifically, we describe patterns of inhibin A and B secretion in the context of the female reproductive cycle. Second, we review molecular mechanisms of inhibin subunit regulation. Third, while inhibins are best known for their role in pituitary FSH regulation, other functions of the ligands are becoming better understood. We review the animal and human literature addressing the possible role of inhibins in gonadal cancers. While we know "what" inhibins do in various contexts, we have a very limited understanding of "how" the ligands have their effects on target cells. Recently, candidate inhibin receptor molecules have been identified (Draper et al., 1998; Hertan et al., 1999; Lewis et al., 2000; Chung et al., 2000). Next, we detail our current understanding of inhibin signal transduction. Finally, in light of the data reviewed here, we pose questions and outline future directions for inhibin research. While this review is concerned primarily with expression and function of inhibin, activin function and mechanisms of action are described where necessary to shed light on inhibin function. Several reviews of activin's role in reproductive and other processes can be found elsewhere (Woodruff, 1998; Pangas and Woodruff, 2000).
抑制素最初被认为是一种能有效抑制垂体促卵泡激素(FSH)合成和分泌的性激素。尽管非甾体、性腺衍生的抑制物质的概念在20世纪30年代早期就已经实现(McCullagh, 1932),但直到50多年后才完成对激素的鉴定。当时,抑制素是从牛和猪卵泡液中纯化出来的,并被证明以两种形式产生,通过α亚基(18 kDa)和两个密切相关的β亚基(β aa和β ab,约14 kDa)之一的二聚体组装(Ling等,1985;Miyamoto等人,1985;Rivier et al., 1985;Robertson et al., 1985)。α和β aa以及α和β ab亚基的二聚体分别形成抑制素A和抑制素B。在纯化抑制素的过程中,两组还鉴定出抑制素β亚基的同二聚体和异二聚体(Ling et al., 1986;Vale et al., 1986)。这些激素,激活素,被证明能从初级垂体培养物中有效地刺激卵泡刺激素分泌,现在已知在生长和发育中起重要作用(Woodruff, 1998;潘加斯和伍德拉夫,2000)。抑制素和激活素被认为是转化生长因子- β (tgf - β)生长和分化因子超家族的成员,基于α和β亚基中保守的半胱氨酸残基模式,类似于该家族中的其他配体。亚基蛋白的鉴定导致了其cdna的克隆,并随后在几个物种中进行了染色体定位(Mason等人,1985,1986;草料等,1986;Mayo et al., 1986;Esch et al., 1987;Woodruff et al., 1987;Barton et al., 1989;Hiendleder et al., 2000)。另外三种与激活素相关的β亚基(哺乳动物中的β ac和β ae以及非洲爪蟾中的β ad)也已被确定,但似乎在卵泡刺激素调节中不起作用(Hotten等人,1995;Oda et al., 1995;Fang et al., 1996,1997;Loveland et al., 1996;Schmitt等,1996;O'Bryan et al., 2000;Lau et al., 2000)。到目前为止,只报道了一个α亚基。抑制素亚基在各种组织中表达(Meunier等人,1988a, 1988b),但性腺显然是循环抑制素的主要来源(Woodruff等人,1996)。虽然抑制素在某些组织中起副分泌作用(Hsueh等人,1987),但它们最广为人知的作用是作为垂体FSH的内分泌调节剂。激活素也从卵泡液中纯化,但由于循环激活素水平普遍较低,激素的大多数作用可能是旁分泌的(Woodruff, 1998)。过去十年的几篇综述已经清楚而彻底地阐述了抑制素和激活素的特征和调控及其在生殖功能中的作用(Vale等人,1988;应,1988;Woodruff and Mayo, 1990;梅奥,1994;伍德拉夫和马瑟,1995)。在本章中,我们将重点关注抑制素研究的最新进展。首先,我们讨论抑制素异构体的差异调控。具体来说,我们描述抑制素A和B分泌模式在女性生殖周期的背景下。其次,综述了抑制素亚基调控的分子机制。第三,虽然抑制素以其在垂体FSH调节中的作用而闻名,但配体的其他功能正在得到更好的理解。我们回顾了抑制素在性腺癌中的可能作用的动物和人类文献。虽然我们知道抑制素在各种情况下的作用,但我们对配体如何对靶细胞产生影响的理解非常有限。最近,候选抑制素受体分子已被确定(Draper等,1998;Hertan et al., 1999;Lewis et al., 2000;Chung et al., 2000)。接下来,我们详细介绍了我们目前对抑制素信号转导的理解。最后,根据这里回顾的数据,我们提出了问题并概述了抑制素研究的未来方向。虽然这篇综述主要关注抑制素的表达和功能,但激活素的功能和作用机制也在必要的地方进行了描述,以阐明抑制素的功能。关于激活素在生殖和其他过程中的作用的若干评论可以在其他地方找到(Woodruff, 1998;潘加斯和伍德拉夫,2000)。